Clinical Trial

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Name: Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers — clinical trial record (NCT07140757)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-22.

Trial Details

NCT Number	NCT07140757
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	Low Risk, Papillary Thyroid Cancer, Radiofrequency Ablation
Enrollment	50 participants
Start Date	2025-08-18
Primary Completion	2028-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-11